Trials / Completed
CompletedNCT00505388
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,137 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This patient follow-up programme was designed to describe the extent of Symbicort use in patients prescribed Symbicort as maintenance and reliever therapy in routine clinical practice in comparison with the already documented use of Symbicort as maintenance and reliever therapy in clinical therapies
Conditions
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2007-07-23
- Last updated
- 2020-01-18
Locations
695 sites across 12 countries: Belgium, Bulgaria, Czechia, Denmark, Germany, Greece, Hungary, Netherlands, Norway, Portugal, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00505388. Inclusion in this directory is not an endorsement.